Table 2.
Summary of clinical variables stratified by use of antihistamines.
| Parameter | Antihistamines Use | No Antihistamines Use | p Value |
|---|---|---|---|
| Change in BMI/year (%/year) | 11.42 ± 3.86 (*) | 4.57 ± 0.65 | 0.0444 |
| Change in BMI percentile/year (%/year) | 1.17 ± 0.39 (*) | −0.05 ± 0.07 | 0.0008 |
| Change in BMI percentile/year (%/year) in female participants | 0.71 ± 0.14 (*) | −0.085 ± 0.13 | 0.0007 |
| Change in BMI percentile/year (%/year) in male participants | 2.18 ± 0.60 (*) | −0.021 ± 0.40 | 0.011 |
| Change in BMI z-score/year | 0.23 ± 0.08 (*) | −0.01 ± 0.01 | 0.0016 |
| Change in BMI z-score/year in female participants |
0.13 ± 0.02 (*) | −0.027 ± 0.02 | 0.0004 |
| Change in BMI z-score/year in male participants |
0.44 ± 0.12 (*) | 0.0049 ± 0.08 | 0.018 |
| Total cholesterol (mg/dL) | 147.83 ± 8.11 (*) | 170.59 ± 6.18 | 0.0313 |
| Low-density lipoprotein (mg/dL) | 73.75 ± 6.74 (*) | 102.35 ± 6.46 | 0.0058 |
| High-density lipoprotein (mg/dL) | 45.33 ± 2.92 | 40.35 ± 2.65 | 0.2239 |
| Triglycerides (mg/dL) | 147.58 ± 25.93 | 147.94 ± 15.78 | 0.9901 |
| Fasting glucose (mg/dL) | 97.85 ± 1.96 | 106.37 ± 8.08 | 0.3986 |
| Aspartate aminotransferase (U/L) | 38.62 ± 6.40 | 54.42 ± 10.20 | 0.2494 |
| Alanine aminotransferase (U/L) | 65.38 ± 15.53 | 96.00 ± 15.63 | 0.1743 |
Values are means ± SEM; * indicates a significant difference (p < 0.05) between study groups (antihistamine users and participants without antihistamine use).